Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance of Effect of Duloxetine 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain
2005-004188-50Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of duloxetine in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Brief Pain Inventory (BPI) 24-hour average pain item score. Started Feb 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-004188-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004188-50.